当前位置：
X-MOL 学术
›
Bioorg. Med. Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Discovery and optimization of dihydropteridone derivatives as novel PLK1 and BRD4 dual inhibitor for the treatment of cancer
Bioorganic & Medicinal Chemistry ( IF 3.5 ) Pub Date : 2024-01-18 , DOI: 10.1016/j.bmc.2024.117609 Jiuyu Liu , Jingxuan Huang , Kang Wang , Yuan Li , Chunting Li , Yanli Zhu , Xinzi He , Yating Zhang , Yanfang Zhao , Changliang Hu , Zhiguo Xi , Minghui Tong , Zhiwei Li , Ping Gong , Yunlei Hou
Bioorganic & Medicinal Chemistry ( IF 3.5 ) Pub Date : 2024-01-18 , DOI: 10.1016/j.bmc.2024.117609 Jiuyu Liu , Jingxuan Huang , Kang Wang , Yuan Li , Chunting Li , Yanli Zhu , Xinzi He , Yating Zhang , Yanfang Zhao , Changliang Hu , Zhiguo Xi , Minghui Tong , Zhiwei Li , Ping Gong , Yunlei Hou
|
[Display omitted]
中文翻译：
作为新型 PLK1 和 BRD4 双重抑制剂的二氢蝶啶酮衍生物的发现和优化用于治疗癌症
[显示省略]
更新日期：2024-01-18
中文翻译：
作为新型 PLK1 和 BRD4 双重抑制剂的二氢蝶啶酮衍生物的发现和优化用于治疗癌症
[显示省略]
京公网安备 11010802027423号